CollPlant Biotechnologies Ltd. (CLGN) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$3.58

From 52W high−85.70%

Volume28938.00

Market cap$6.73M

P/E (TTM)—

P/S (TTM)21.2x

Div yield—

Key dataOct 19, 2026

Open

$3.58

From 52W high

−85.70%

Volume

28938.00

Market cap

$6.73M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.6x

P/E (TTM)

—

RSI (14)

47.0

MomentumView details →

1D Return

−1.79%

YTD Return

−74.71%

SummaryUpdated Jun 1, 2026

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) is an Israeli biotechnology company founded in 2004 and headquartered in Rehovot, Israel. The company went public on NASDAQ in January 2018. CollPlant specializes in regenerative and aesthetic medicine, focusing on developing innovative medical products based on recombinant human collagen produced through proprietary plant-based genetic engineering technology. The company operates in the rapidly evolving biotechnology sector, developing solutions for tissue regeneration, wound care, and aesthetic medicine applications.

Ask drillr about CollPlant Biotechnologies Ltd. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.6x

EV/Sales

20.3x

P/S (TTM)

21.2x

P/B (TTM)

2.3x

ProfitabilityView details →

Gross Margin

−521.70%

Net Margin

−3934.91%

EBITDA Margin

−3621.70%

ROE (TTM)

−424.89%

ROA (TTM)

−173.86%

Asset Turnover

0.04x

GrowthView details →

Revenue YoY

−86.76%

EPS YoY

−94.81%

FCF YoY

−9.05%

Revenue CAGR 3Y

+99.41%

EPS CAGR 3Y

+35.17%

EBITDA YoY

+2.92%

MomentumView details →

1D Return

−1.79%

YTD Return

−74.71%

1Y Return

−85.78%

RSI (14)

47.0

vs 50D SMA

−0.56%

vs 200D SMA

−36.92%

Capital & dividendView details →

Debt/Equity

0.90x

Current Ratio

1.57x

Quick Ratio

1.35x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$1.89

EPS Surprise

22.86%

Beats (12Q)

4/12

Next Q EPS Est

−$0.50

Avg Surprise (4Q)

−67.53%

Rev Surprise

−77.50%

Financials snapshotView financials →

Revenue (TTM)

318000.00

Net Income (TTM)

−12.51M

Op. CF (TTM)

−11.61M

Next earningsDec 2, 2026 →

Latest newsMore news →

LightSolver, a subsidiary of CollPlant Biotechnologies, filed a U.S. provisional patent application with the USPTO expanding its all-optical, laser-based photonic computing platform to advanced scientific and engineering simulations.14d ago

Similar companies

Exicure, Inc.XCUR Aprea Therapeutics, Inc.APRE Skye Bioscience, Inc.SKYE FibroBiologics, Inc. Common StockFBLG Nutriband Inc.NTRBW Ainos, Inc.AIMD Find similar companies →

Latest newsMore news →

CollPlant Biotechnologies Ltd entered definitive agreements to issue and sell 989,301 ordinary shares or equivalents and warrants to purchase up to 1,483,952 shares in a private placement at a combined price of $3.74 per share and accompanying warrants.10d ago LightSolver, a subsidiary of CollPlant Biotechnologies, filed a U.S. provisional patent application with the USPTO expanding its all-optical, laser-based photonic computing platform to advanced scientific and engineering simulations.14d ago CollPlant Biotechnologies will host an investor webinar on September 17, 2026 to present LightSolver.40d ago